World Health Organization
Avenue Appia 20
1211
Geneva 27
Tel: 00-41-22-791-21-11
Fax: +00-41-22-791-3111
Website: http://www.who.int/
Email: info@who.int
483 articles with World Health Organization
-
The changes are unlikely to help people in developing countries but could reduce innovation among biopharma companies and ultimately do more harm than good.
-
The European Center for Disease Prevention and Control said the number of unusual pediatric hepatitis cases has reached 450, double the number reported two weeks ago.
-
Despite having infinitely better global communications, exact figures are hard to come by for COVID-19 fatalities. Here's a look at that story and more COVID-19 news.
-
The WHO issued an alarming statement that details a 79% increase in child measles outbreaks globally, as well as a warning that 11 countries have reported peculiar acute cases of hepatitis in children.
-
Gilead’s Veklury made massive profits, but as more vaccine boosters arrive and more people become immune to the virus, the future of the antiviral is in question.
-
How many boosters are enough to protect against COVID-19 infection? This question has been at the forefront of the minds of everyone as news crops up about yearly boosters.
-
WHO is raising flags against the concerns surrounding a mysterious illness (related to pediatric liver disease) that is increasing following a reported death.
-
The FDA has now approved the first treatment for COVID-19 in young children, expanding its approval for Gilead's Veklury to children who are at least 28 days old and weigh at least three kilograms.
-
The WHO has indicated support for Pfizer’s Paxlovid and reversing a previous decision on using antiviral remdesivir, now recommending it in cases of mild to moderate COVID-19.
-
COVID-19 has killed more than six million people worldwide and almost one million in the U.S. And the pandemic isn’t over yet. Read on for that and more updates about COVID-19.
-
New data from Roche's study on the use of Ocrevus to treat patients with primary and secondary progressive multiple sclerosis demonstrated positive outcomes.
-
Two companies in India have halted vaccine manufacturing, which could be a sign that the pandemic may be coming to an end. For that and more COVID-19 news, continue reading.
-
Although the data suggests the vaccines are extremely effective and generally safe, analysis is still coming in about adverse events as well as effectiveness in specific patient populations.
-
A new study shows that a second COVID booster is highly effective in preventing death in older adults.
-
In honor of March 24, World TB Day, BioSpace looks at clinical trials and eradication efforts occurring today.
-
Researchers at Albert Einstein College of Medicine have cleverly developed a vaccine for pancreatic cancer by using the adaptive immunity already present in nearly all of the global population.
-
On Wednesday, the World Health Organization indefinitely postponed the evaluation of Russia's Sputnik V COVID-19 vaccine due to the ongoing conflict in Ukraine.
-
Codagenix is entering the vaccine arena with a possible new frontrunner in protection: CoviLiv. It's an intranasal COVID vaccine that provides hope against subvariants.
-
Now that Omicron is becoming less common, its sister variant, BA.2, seems to be surging worldwide and in the U.S. For that and more, continue reading.
-
The Russian invasion of Ukraine has hampered Ukrainian research to develop new treatments for infection from the SARS-CoV-2 virus and increased the risk of spreading virulent pathogens.